Views on Alembic Pharmaceuticals 4QFY2014 result - Angel Broking

Views of Ms. Sarabjit Kour Nangra (VP Research-Pharma, Angel Broking) on Alembic Pharmaceuticals 4QFY2014 result:

"For 4QFY2014, Alembic is expected to post robust numbers, on sale and OPM front. The company, net sales came in at Rs. 463cr V/s expected Rs. 492cr, a yoy growth of 23.0%.The sales growth will be driven by exports. While, the domestic sales grew by 14% yoy, while exports grew by 58.6% yoy. The exports grew on account of the international generics and branded which grew by 99% and 32% yoy. On the operating front, it posted EBIDTA margins of 19.6% V/s expected margins of 18.7%, an expansion of 230bps. On the net profit front, the company posted net profits of Rs. 61.3cr V/s expected Rs. 70cr, a yoy growth of 40.1%.We maintain our neutral on the stock."

Alembic Pharmaceuticals (CMP: Rs. 306/ TP: Rs. / Upside :)

Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.294.9 as compared to the previous close of Rs. 297.55. The total number of shares traded during the day was 51446 in over 3131 trades.

The stock hit an intraday high of Rs. 301.65 and intraday low of 291.35. The net turnover during the day was Rs. 15229011.

Source : Equity Bulls

Keywords